Is Eczema Herpeticum Contagious and How Does It Spread?

Eczema herpeticum is contagious because it is caused by herpes simplex virus (HSV), and the fluid-filled blisters it produces are teeming with active virus. The condition itself is not a separate disease you “catch” but rather what happens when HSV infects skin already compromised by atopic dermatitis or another inflammatory skin condition. That distinction matters: the virus can spread from person to person, but only someone with an underlying skin barrier problem is likely to develop the widespread, painful eruption known as eczema herpeticum. Understanding the routes of transmission, who is actually vulnerable, and how serious the condition can become helps separate reasonable caution from unnecessary panic.

What Eczema Herpeticum Actually Is

Eczema herpeticum occurs when HSV, usually type 1 but sometimes type 2, takes hold in skin that is already inflamed and structurally weakened. It affects roughly 3% of people with atopic dermatitis and can cause life-threatening complications if it spreads unchecked.¹ The characteristic presentation is clusters of small, dome-shaped blisters that often appear “punched out,” quickly erode, and crust over. These lesions tend to show up first in areas where eczema is worst, then may spread to involve large patches of skin. Fever, malaise, and swollen lymph nodes frequently accompany the rash.

It is worth being clear about what makes eczema herpeticum different from a typical cold sore. A cold sore is a small, localized outbreak of HSV on otherwise healthy skin. Eczema herpeticum is what happens when the virus exploits a broken-down skin barrier and spreads across a much wider area. The virus is the same; the battlefield is different. That broken barrier is the reason the condition can become dangerous in ways that a normal cold sore almost never does.

How the Virus Spreads

HSV spreads through direct skin-to-skin contact with someone who has an active outbreak, and this is the primary route for eczema herpeticum as well. A parent or partner with an active cold sore kissing a child or adult who has eczema is a classic scenario. The virus enters through the compromised, inflamed skin and begins replicating rapidly because the normal barriers that would slow it down are already damaged.

Research has also identified indirect routes of transmission. A study detecting HSV DNA in non-herpetic skin areas of patients with eczema herpeticum found evidence suggesting two indirect pathways: manual scratching of herpetic lesions, which transfers virus to the person’s own unaffected skin, and contact with contaminated objects like bath towels or underwear.² This means that someone with eczema herpeticum can spread the infection to new areas of their own body through scratching, and that shared personal items can theoretically carry the virus to another person whose skin is vulnerable.

An important nuance: HSV does not survive long on dry surfaces. Fomite transmission (picking it up from a doorknob, for example) is far less likely than direct contact. The objects most plausibly involved are those that stay moist and come into prolonged contact with skin, like towels, washcloths, and shared bedding.

Who Is Actually at Risk

Healthy, intact skin is a remarkably effective barrier against HSV. If you have no underlying skin condition, touching someone with eczema herpeticum is unlikely to give you eczema herpeticum. You could, in theory, pick up HSV and develop a cold sore in the usual way, but the widespread disseminated infection that defines eczema herpeticum requires a compromised skin barrier to take hold.

The people at genuine risk are those with active atopic dermatitis, especially severe or widespread eczema. Not everyone with eczema is equally vulnerable, though. Research has identified specific factors that raise the risk substantially:

Filaggrin mutations: Filaggrin is a protein critical for building a strong outer skin layer. A specific mutation (R501X) that is already one of the strongest genetic predictors of atopic dermatitis confers an even greater risk for eczema herpeticum, in both people of European and African ancestry.³ In practical terms, people whose eczema is partly driven by a defective skin barrier at the genetic level are more susceptible.
Low cathelicidin levels: Cathelicidins are antimicrobial peptides the skin produces to fight off infections. Patients who develop eczema herpeticum have been found to produce significantly less of a key cathelicidin called LL-37 compared to eczema patients who never develop the condition. In lab testing, LL-37 kills HSV effectively at concentrations normally found in skin, and mice lacking cathelicidins show much higher viral replication.⁴
Reduced interferon-beta: A study comparing eczema patients with and without a history of eczema herpeticum found that those who developed the condition had significantly lower blood levels of interferon-beta, a signaling molecule that helps coordinate the body’s antiviral response.⁵

These factors help explain why the majority of people with eczema never develop eczema herpeticum despite widespread exposure to HSV in the general population. It takes a specific combination of compromised skin barrier, weakened local antimicrobial defense, and impaired antiviral immune signaling for the condition to take hold.

Patterns That Predict Who Gets Hit Hardest

Beyond genetics and immune markers, certain clinical patterns are associated with higher risk. People who developed eczema early in life and have had a chronic, recurring course into adulthood are more likely to experience eczema herpeticum.⁵ Eczema concentrated on the head and neck seems to carry a higher risk as well, possibly because these areas are more frequently exposed to HSV through kissing, touching the face, or contact with oral secretions.

Higher total IgE levels (a marker of stronger allergic tendency) and sensitization to common airborne allergens and to the skin yeast Malassezia are also more common among eczema patients who go on to develop eczema herpeticum.⁵ In plain terms, the more “allergically driven” your eczema is, the higher your risk appears to be. This fits with the understanding that the type of immune response dominant in severe atopic dermatitis (heavily skewed toward allergy) comes at the cost of the antiviral defenses the skin needs to keep HSV in check.

Children and Infants Face Greater Danger

Eczema herpeticum can strike at any age, but children are disproportionately affected, partly because atopic dermatitis is most common and most active in early childhood. A study of 79 pediatric patients found that over three-quarters had a generalized eruption at the time they were diagnosed, more than half had fever, and about one in ten had eye involvement.⁶ The hospitalization rate was high: 57% of the children in that study required inpatient care.

Infants under one year old are especially vulnerable. In the same study, being younger than one year was one of the strongest predictors of hospitalization, with roughly seven times the odds compared to older children.⁶ Fever and systemic symptoms like poor feeding and lethargy also strongly predicted the need for hospital admission. Boys were about three times more likely to be hospitalized than girls, for reasons that remain unclear.

For parents of a child with eczema, this is the most practically important takeaway on the transmission question. Anyone with an active cold sore should avoid kissing the child or touching the child’s skin. This includes well-meaning relatives. The virus does not know it is being transmitted lovingly. A single kiss on a cheek covered with eczema patches can trigger a serious, potentially sight-threatening or life-threatening infection in a baby.

When It Becomes Dangerous

Most cases of eczema herpeticum respond to antiviral medication when caught early. The real danger comes from delayed diagnosis, very widespread involvement, or bacterial superinfection. The open, eroded skin left behind by the viral blisters is a welcoming entry point for bacteria, particularly Staphylococcus aureus, which already colonizes the skin of most people with atopic dermatitis at higher-than-normal rates.

Case reports illustrate how quickly things can deteriorate. In one patient with a pre-existing skin lymphoma, disseminated herpes simplex with concurrent S. aureus sepsis proved fatal.⁷ In a pediatric case, eczema herpeticum with eye involvement progressed rapidly to orbital cellulitis despite early treatment with oral antivirals and antibiotics.⁸ These are unusual outcomes, but they underscore why eczema herpeticum is treated as a medical emergency rather than a routine skin problem.

Eye involvement deserves special mention. When the virus reaches the cornea, it can cause herpetic keratitis, which if untreated can lead to scarring and permanent vision loss. About one in ten children with eczema herpeticum in the pediatric study mentioned earlier had eye involvement at presentation.⁶ Any new blisters appearing near or around the eyes in someone with eczema should prompt urgent medical evaluation.

Recurrence and the Problem of Latency

Like all herpes simplex infections, eczema herpeticum can come back. Once HSV establishes itself in nerve ganglia, it stays there permanently. Periodic reactivation can send the virus back to the skin surface, potentially triggering another episode of eczema herpeticum in someone whose skin barrier remains compromised. A European multicenter study found that early onset of atopic dermatitis was a risk factor for recurrent eczema herpeticum specifically.⁹

This has direct implications for contagion. Someone who has had eczema herpeticum before can become contagious again during a recurrence, even without a new exposure from another person. The virus is already in their body, waiting for the right conditions to reactivate. Stress, illness, immunosuppressive medications, and poorly controlled eczema flares can all serve as triggers for reactivation, though predicting exactly when and whether a recurrence will happen is not possible.

During asymptomatic periods, the risk of transmitting HSV is much lower but not zero. Asymptomatic viral shedding, where the virus reaches the skin surface without producing visible symptoms, is a well-documented feature of HSV infection. Whether this shedding is enough to trigger eczema herpeticum in a close contact with eczema is less clear, but the possibility is real.

Practical Steps to Reduce Transmission

Preventing eczema herpeticum comes down to two strategies: limiting exposure to HSV and keeping the skin barrier as strong as possible. Neither is foolproof, but both meaningfully reduce risk.

To limit exposure:

Avoid skin contact during outbreaks: If you or someone in the household has an active cold sore, avoid kissing and direct skin-to-skin contact with anyone who has eczema, especially young children.
Keep towels and washcloths separate: Given the evidence for indirect transmission via moist personal items, people with active herpes outbreaks should not share towels, washcloths, or razors with household members who have eczema.²
Wash hands frequently: HSV can be transferred from a cold sore to the hands and then to someone else’s skin. Regular hand washing during an active outbreak reduces this risk.
If you have eczema herpeticum, minimize scratching: Scratching your own blisters spreads the virus to new areas of your skin, potentially worsening the infection.

To strengthen the skin barrier:

Keep eczema well controlled: Inflamed, broken-down skin is the entry point for HSV. Working with a dermatologist to manage flares with appropriate moisturizers and, when needed, anti-inflammatory treatments reduces the window of vulnerability.
Moisturize consistently: Daily emollient use helps maintain the physical barrier function of the skin even when eczema is not actively flaring.
Address infection promptly: If you suspect eczema herpeticum (new clusters of painful, uniform blisters on eczema-affected skin, especially with fever), seek medical attention immediately. Early antiviral treatment makes a substantial difference in outcomes.

Can Someone Without Eczema Catch It?

This is one of the most common points of confusion. If you do not have atopic dermatitis or another chronic inflammatory skin condition, you cannot develop eczema herpeticum. What you can develop is a standard HSV infection: a cold sore, genital herpes, or in rare cases herpetic whitlow (a finger infection). These are nuisance infections for most healthy people but are not the same as eczema herpeticum.

The exception is people with other conditions that disrupt the skin barrier. Burns, severe contact dermatitis, Darier disease, pemphigus, and other blistering or barrier-disrupting skin conditions can all, in theory, provide the damaged landscape that HSV needs to disseminate widely. Some immunosuppressive medications used for organ transplants or autoimmune diseases can also increase vulnerability. But for the average person with intact skin and a functioning immune system, eczema herpeticum is not a personal risk even with direct exposure to someone who has it.

This distinction is worth keeping in mind for families with a child with eczema. The child’s sibling who does not have eczema is at minimal risk of developing eczema herpeticum from the affected child. The child with eczema, on the other hand, needs to be protected from HSV exposure. The directionality of risk is asymmetric, and understanding that asymmetry helps families focus their precautions where they actually matter.

Eczema Herpeticum vs. Other Infections That Mimic It

Part of why eczema herpeticum gets diagnosed late is that it can look like a bacterial skin infection or a severe eczema flare. Impetigo, which is caused by bacteria and is also common in people with eczema, produces honey-colored crusted lesions that can superficially resemble healing eczema herpeticum. A severe eczema flare with intense scratching damage can also create erosions that mimic viral blisters.

The clinical clues that point toward eczema herpeticum include the uniformity of the blisters (they tend to be the same size and shape, often described as “monomorphic”), painful rather than merely itchy lesions, and the presence of fever or feeling systemically unwell. A viral swab or PCR test can confirm the diagnosis quickly. Getting this right matters because the treatments are different: antibiotics for bacterial infection, antivirals for eczema herpeticum. Giving one without the other when both are present, as they frequently are, can lead to worsening despite treatment.

Eczema patients who have experienced eczema herpeticum before often learn to recognize the early signs and seek help faster in subsequent episodes. That familiarity, uncomfortable as it is, works in their favor. The evidence consistently shows that outcomes are better when antiviral therapy starts early, before the infection has time to spread widely across the skin or reach the eyes.⁸

1
PubMed. Eczema Herpeticum: Clinical and Pathophysiological Aspects
2
Dermatology. Detection of Herpes simplex Virus DNA in Non-Herpetic Areas of Patients with Eczema herpeticum
3
PubMed Central. Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum
4
PubMed Central. Cathelicidin Deficiency Predisposes to Eczema Herpeticum
5
Journal of Investigative Dermatology. Atopic Dermatitis Complicated by Eczema Herpeticum: Clinical and Immunological Characteristics
6
PubMed. Eczema herpeticum in children: clinical features and factors predictive of hospitalization
7
PubMed. Fatal outcome due to bacterial superinfection of eczema herpeticum in a patient with mycosis fungoides
8
PubMed Central. Severe Eczema Herpeticum With Ocular Involvement Leading to Orbital Cellulitis: A Pediatric Case Report
9
PubMed. Recurrent eczema herpeticum – a retrospective European multicenter study evaluating the clinical characteristics of eczema herpeticum cases in atopic dermatitis patients